1. Wang J and Chen Z. Neuromodulation for Pain Management. Adv. Exp. Med. Biol. 2019; 1101: 207-23. [
DOI:10.1007/978-981-13-2050-7_8]
2. Jensen TS, Baron R, Haanpää M, Kalso E, Loeser JD, Rice AS and Treede R-D. A new definition of neuropathic pain. Pain. 2011; 152(10): 2204-05. [
DOI:10.1016/j.pain.2011.06.017]
3. Colloca L, Ludman T, Bouhassira D, Baron R, Dickenson AH, Yarnitsky D, Freeman R, Truini A, Attal N, Finnerup NB, Eccleston C, Kalso E, Bennett DL, Dworkin RH and Raja SN. Neuropathic pain. Nat. Rev. Dis. Primers 2017; 3: 17002. [
DOI:10.1038/nrdp.2017.2]
4. Costigan M, Scholz J and Woolf CJ. Neuropathic pain: a maladaptive response of the nervous system to damage. Annu. Rev. Neurosci. 2009; 32: 1-32. [
DOI:10.1146/annurev.neuro.051508.135531]
5. Malcangio M. Role of the immune system in neuropathic pain. Scand. J. Pain. 2019; Nov 14 (In press). [
DOI:10.1515/sjpain-2019-0138]
6. Chattopadhyay I, Biswas K, Bandyopadhyay U and Banerjee RK. Turmeric and curcumin: Biological actions and medicinal applications. Current Science-Bangalore. 2004; 87: 44-53.
7. Ceyhan D, Kocman A E, Yildirim E, Ozatik O, Aydin S and Kose A. Comparison of the effects of curcumin, tramadol and surgical treatments on neuropathic pain induced by chronic constriction injury in rats. Turk. Neurosurg. 2018; 28(2): 288-95. [
DOI:10.5137/1019-5149.JTN.19824-17.0]
8. Aggarwal BB, Kumar A and Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 2003; 23 (1/A): 363-98.
9. Ghosh S, Banerjee S and Sil PC. The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: A recent update. Food Chem. Toxicol. 2015; 83: 111-24. [
DOI:10.1016/j.fct.2015.05.022]
10. Rahmani AH, Alsahli MA, Aly SM, Khan MA and Aldebasi YH. Role of curcumin in disease prevention and treatment. Adv. Biomed. Res. 2018; 7: 38. [
DOI:10.4103/abr.abr_147_16]
11. Allegra A, Innao V, Russo S, Gerace D, Alonci A and Musolino C. Anticancer activity of curcumin and its analogues: preclinical and clinical studies. Cancer Invest. 2017; 35(1): 1-22. [
DOI:10.1080/07357907.2016.1247166]
12. Sharma S, Kulkarni SK, Agrewala JN and Chopra K. Curcumin attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain. Eur. J. Pharmacol. 2006; 536(3): 256-61. [
DOI:10.1016/j.ejphar.2006.03.006]
13. Safakhah H, Taghavi T, Rashidy-Pour A, Vafaei A, Sokhanvar M, Mohebbi N and Rezaei-Tavirani M. Effects of saffron (Crocus sativus L.) stigma extract and its active constituent crocin on neuropathic pain responses in a rat model of chronic constriction injury. IJPR. 2016; 15(1): 253.
14. Safakhah H A, Bazargani A and Ghanbari A. Effects of forced exercise on neuropathic pain induced by chronic constriction injury of sciatic nerve in male rat. Koomesh 2016: 411-8.
15. Zhang L, Ding X, Wu Z, Wang M and Tian M. Curcumin alleviates pain and improves cognitive impairment in a rat model of cobra venom-induced trigeminal neuralgia. J. Pain. Res. 2018; 11: 1095. [
DOI:10.2147/JPR.S162668]
16. Kukkar A, Singh N and Jaggi A S. Attenuation of neuropathic pain by sodium butyrate in an experimental model of chronic constriction injury in rats. J. Formos. Med. Assoc. 2014; 1 (12): 92-8. [
DOI:10.1016/j.jfma.2013.05.013]
17. Jaggi A S, Jain V and Singh N. Animal models of neuropathic pain. Fundam. Clin. Pharmacol. 2011; 25(1): 1-28. [
DOI:10.1111/j.1472-8206.2009.00801.x]
18. Jaggi AS and Singh N. Exploring the potential of telmisartan in chronic constriction injury-induced neuropathic pain in rats. Eur. J. Pharmacol. 2011; 667 (1-3): 215-21. [
DOI:10.1016/j.ejphar.2011.06.017]
19. Xiao WH, Zheng H and Bennett GJ. Characterization of oxaliplatin-induced chronic painful peripheral neuropathy in the rat and comparison with the neuropathy induced by paclitaxel. Neuroscience 2012; 203: 194-206. [
DOI:10.1016/j.neuroscience.2011.12.023]
20. Lim GP, Chu T, Yang F, Beech W, Frautschy SA and Cole GM. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J. Neurosci. 2001; 21(21): 8370-7. [
DOI:10.1523/JNEUROSCI.21-21-08370.2001]
21. Xiao WH, Bennett GJ. Effects of mitochondrial poisons on the neuropathic pain produced by the chemotherapeutic agents, paclitaxel and oxaliplatin. Pain. 2012 Mar 1; 153(3): 704-9. [
DOI:10.1016/j.pain.2011.12.011]
22. Bennett GJ. What is spontaneous pain and who has it? J. Pain. 2012; 13(10): 921-9. [
DOI:10.1016/j.jpain.2012.05.008]
23. He Y, Yue Y, Zheng X, Zhang K, Chen S and Du Z. Curcumin, inflammation, and chronic diseases: how are they linked? Molecules. 2015; 20(5): 9183-213. [
DOI:10.3390/molecules20059183]
24. Sharma S, Chopra K and Kulkarni S K. Effect of insulin and its combination with resveratrol or curcumin in attenuation of diabetic neuropathic pain: participation of nitric oxide and TNF‐alpha. Phytother. Res. 2007; 21(3): 278-83. [
DOI:10.1002/ptr.2070]
25. Panchal HD, Vranizan K, Lee CY, Ho J, Ngai J and Timiras PS. Early anti-oxidative and anti-proliferative curcumin effects on neuroglioma cells suggest therapeutic targets. Neurochem. Res. 2008; 33(9): 1701-10. [
DOI:10.1007/s11064-008-9608-x]
26. Siddiqui M, Kashyap M, Kumar V, Tripathi V, Khanna V, Yadav S and Pant A. Differential protection of pre-, co-and post-treatment of curcumin against hydrogen peroxide in PC12 cells. Hum. Exp. Toxicol. 2011; 30(3): 192-8. [
DOI:10.1177/0960327110371696]